A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand
Psychiatry Research Communications · 2024-09 · 4 (3) · 100177
DOI: 10.1016/j.psycom.2024.100177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry Research Communications, 2024-09. Verfasst von Malcolm Hopwood und 7 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hopwood, M., Scott, E. M., Codyre, D., Barton, D., Puig, A., King, J., Joks, G., & Hickie, I. B. (2024). A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand. Psychiatry Research Communications, 4(3), 100177. https://doi.org/10.1016/j.psycom.2024.100177
Vancouver
Hopwood M, Scott EM, Codyre D, Barton D, Puig A, King J, et al. A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand. Psychiatry Research Communications. 2024;4(3):100177. doi:10.1016/j.psycom.2024.100177
BibTeX
@article{Hopwood2024,
author = {Hopwood, Malcolm and Scott, Elizabeth M. and Codyre, David and Barton, David and Puig, Andrea and King, Jarrad and Joks, Gero and Hickie, Ian B.},
title = {A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand},
journal = {Psychiatry Research Communications},
year = {2024},
volume = {4},
number = {3},
pages = {100177},
doi = {10.1016/j.psycom.2024.100177}
}
EUVIMED